Clinical Trial Update: Optimization of SPECT Imaging [NA]

View source ↗

Summary

A clinical trial evaluating optimization of single-photon emission computed tomography (SPECT) imaging in patients with Coronary Artery Disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Artery Disease | NA | Status: TERMINATED